Jennifer Gnass Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 536 March Ave, Healdsburg, CA 95448 Phone: 707-921-6399 |
Corinne Meadows-efram, LMFT, PPSC Counselor - School Medicare: Not Enrolled in Medicare Practice Location: 825 University St, Healdsburg, CA 95448 Phone: 707-490-2504 |
Katherine Julia Wells, LMFT Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 411 East St, Healdsburg, CA 95448 Phone: 707-433-3351 |
Dr. Elizabeth Anne Caine, PHD Counselor - Mental Health Medicare: Accepting Medicare Assignments Practice Location: 1381 University St, Healdsburg, CA 95448 Phone: 707-433-5494 |
News Archive
A team of researchers at Princeton University and The Cancer Institute of New Jersey has identified a long-sought gene that is fatefully switched on in 30 to 40 percent of all breast cancer patients, spreading the disease, resisting traditional chemotherapies and eventually leading to death.
Cheasanee Huette, a 20-year-old college student in Northern California, is worried. Two years ago, knowing she was protected by the Affordable Care Act's guarantees of coverage for preexisting conditions, she decided to find out if she carried the same genetic mutation that eventually killed her mother.
The annual Century for the Cure bike ride that has raised more than $1 million since 2005 for research at The Cancer Institute of New Jersey is now making it possible for new scientific exploration in the area of hematologic malignancies.
The discovery of new genetic mutations involved in inflammatory intestinal disorders could lead to a better understanding of these common conditions, two scientists told the annual conference of the European Society of Human Genetics today (Monday 2 June).
Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Science Translational Medicine by a team from the Perelman School of Medicine at the University of Pennsylvania and the Novartis Institutes for BioMedical Research.
› Verified 1 days ago